Post-et Myelofibrosis
📧 Sign up to get email alerts when something new happens for Post-et Myelofibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF [Phase 1, Phase 2]
Clinical trial update for KRT-232 in combination with TL-895 for myelofibrosis and KRT-232 for JAK inhibitor-intolerant MF, covering Phase 1…